Biomarker Opioids

<div><div><div>In 2018, seeking innovative strategies, Tempe, in partnership with Arizona State University's Biodesign Institute, was the first city in the United States to incorporate wastewater data with other population health data to make strategic and operational decisions about the opioid public health crisis. </div><div><br /></div><div>This data, alongside other authoritative data, informs educational and service programs to make progress towards Tempe's goal to achieve an end to opioid misuse and abuse as measured by the percentage of “opioid abuse probable” Emergency Medical Services Calls (<a href='https://safe-and-secure-communities-tempegov.hub.arcgis.com/pages/addressing-opioids' target='_blank' rel='nofollow ugc noopener noreferrer'>Performance Measure 1.31</a>).</div><div><br /></div><div>Tempe’s Wastewater BioIntel Program tests wastewater for the presence of seven opioid-related analytes: </div><div><br /></div><div>Opioid parent drug compounds such as Fentanyl, Oxycodone, Codeine, including the illegally made opioid parent drug compound heroin; and, opioid metabolite drug compounds including Norfentanyl, 6-Acetylmorphine and Noroxycodone. </div></div><div><br /></div><div>Site is Google Translate enabled. </div></div><div><br /></div>DO NOT DELETE OR MODIFY THIS ITEM. This item is managed by the ArcGIS Hub application. To make changes to this page, please visit https://tempegov.hub.arcgis.com:/overview/edit.